Product
Resveratrol, Quercetin, and Curcumin (RQC)
1 clinical trial
2 indications
Indication
Alzheimer's diseaseIndication
Mild Cognitive ImpairmentClinical trial
A Randomized Phase II Study to Evaluate Oral RQC for the Prevention of Alzheimer's Disease and Retinal Amyloid-β in Cognitively Unimpaired AdultsStatus: Not yet recruiting, Estimated PCD: 2027-07-01